In conclusion, non-CIC breast cancer cells feature oncolytic adenovirus recognition by TLR9 and TLR2 and intact TLR trafficking, whereas CIC have defects in trafficking of TLR9 and co-factor MyD88 and lack of TLR2. This evidence concerns the gene TLR2 and breast cancer.